Form 4 for TMDX TransMedics Group, Inc.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001193125-26-092241 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-04 | 2026-03-02+ | TMDX | Hernandez Gerardo | CFO | S - Sale+OE | $146.81 | -7,611 | 14.7K | -34% | -$1.12M |
| DM | 2026-03-04 | 2026-03-04 | TMDX | Hernandez Gerardo | CFO | M - OptEx | $71.17 | +7,236 | 20.6K | +54% | +$515.0K |
| DM | 2026-03-04 | 2026-03-04 | TMDX | Hernandez Gerardo | CFO | M - OptEx | $0.00 | -7,236 | 3,975 | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 375 | $139.12 | 14,689 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-04 | M | A | 1,324 | $77.12 | 16,013 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-04 | S | D | 1,324 | $147.21 | 14,689 | D | — | — | (F2) The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 4 | Common | Common Stock | 2026-03-04 | M | A | 5,912 | $69.84 | 20,601 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-04 | S | D | 5,912 | $147.21 | 14,689 | D | — | — | (F2) The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-03-04 | M | D | 5,912 | $0.00 | 13,010 | D | $69.84 · — to 2034-12-09 | 5,912 Common Stock | (F4) The option vested as to 25% of the shares underlying the option on December 2, 2025 and will continue to vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-03-04 | M | D | 1,324 | $0.00 | 3,975 | D | $77.12 · — to 2035-02-24 | 1,324 Common Stock | (F3) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. |